"First-episode psychosis: Structural covariance deficits in salience network correlate with symptoms severity".


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
04 2021
Historique:
received: 13 05 2020
revised: 08 01 2021
accepted: 23 01 2021
pubmed: 2 3 2021
medline: 15 5 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

Patterns of coordinated variations of gray matter (GM) morphology across individuals are promising indicators of disease. However, it remains unclear if they can help characterize first-episode psychosis (FEP) and symptoms' severity. Sixty-seven FEP and 67 matched healthy controls (HC) were assessed with structural MRI to evaluate the existence of distributed GM structural covariance patterns associated to brain areas belonging to salience network. Voxel-based morphometry (VBM) and structural covariance differences, investigated with salience network seed-based Partial Least Square, were applied to explore differences between groups. GM density associations with Raven's intelligent quotient (IQ) and Positive and Negative Syndrome Scale (PANSS) scores were investigated. Univariate VBM results gave trend without significant GM differences across groups. GM and IQ correlated positively in both groups: in FEP, mostly in hippocampus, insula, and fronto-temporal structures, while in HC mostly in amygdala, thalamus and fronto-temporal regions. GM and PANSS scores correlated negatively in FEP, with widespread clusters located in limbic regions. Multivariate analysis showed strong and opposite structural GM covariance with salience network for FEP and HC. Moreover, structural covariance of the salience network in FEP correlated negatively with severity of clinical symptoms. Our study provides evidence supporting the insular dysfunction model of psychosis. Reduced structural GM covariance of the salience network, with its association to symptom's severity, appears a promising morphometry feature for FEP detection.

Sections du résumé

BACKGROUND
Patterns of coordinated variations of gray matter (GM) morphology across individuals are promising indicators of disease. However, it remains unclear if they can help characterize first-episode psychosis (FEP) and symptoms' severity.
METHODS
Sixty-seven FEP and 67 matched healthy controls (HC) were assessed with structural MRI to evaluate the existence of distributed GM structural covariance patterns associated to brain areas belonging to salience network. Voxel-based morphometry (VBM) and structural covariance differences, investigated with salience network seed-based Partial Least Square, were applied to explore differences between groups. GM density associations with Raven's intelligent quotient (IQ) and Positive and Negative Syndrome Scale (PANSS) scores were investigated.
RESULTS
Univariate VBM results gave trend without significant GM differences across groups. GM and IQ correlated positively in both groups: in FEP, mostly in hippocampus, insula, and fronto-temporal structures, while in HC mostly in amygdala, thalamus and fronto-temporal regions. GM and PANSS scores correlated negatively in FEP, with widespread clusters located in limbic regions. Multivariate analysis showed strong and opposite structural GM covariance with salience network for FEP and HC. Moreover, structural covariance of the salience network in FEP correlated negatively with severity of clinical symptoms.
CONCLUSION
Our study provides evidence supporting the insular dysfunction model of psychosis. Reduced structural GM covariance of the salience network, with its association to symptom's severity, appears a promising morphometry feature for FEP detection.

Identifiants

pubmed: 33647856
pii: S0022-3956(21)00055-8
doi: 10.1016/j.jpsychires.2021.01.044
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-420

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Francesca Saviola (F)

CIMeC, Center for Mind/Brain Sciences, University of Trento, Rovereto, Trento, Italy.

Marcella Bellani (M)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Italy.

Cinzia Perlini (C)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Clinical Psychology, University of Verona, Italy.

Letizia Squarcina (L)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Eleonora Maggioni (E)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Domenico Zacà (D)

CIMeC, Center for Mind/Brain Sciences, University of Trento, Rovereto, Trento, Italy.

Antonio Lasalvia (A)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Italy; UOC of Psychiatry, Azienda Ospedaliera Universitaria Integrata (AOUI) of Verona, Italy.

Nicola Dusi (N)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Chiara Bonetto (C)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Italy.

Doriana Cristofalo (D)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Italy.

Franco Alessandrini (F)

Neuroradiology Department, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy.

Giada Zoccatelli (G)

Neuroradiology Department, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy.

Elisa Ciceri (E)

Neuroradiology Department, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy; Department of diagnostic Radiology and Neuroradiology, IRCCS Fondazione Istituto Neurologico Besta, Milano, Italy.

Luca Mesiano (L)

Department of Neurosciences, University of Padova and Azienda Ospedaliera, Padua, Italy.

Enrico Semrov (E)

Department of Mental Health, Reggio Emilia, Italy.

Riccardo Lo Parrino (R)

Department of Mental Health, Florence, Italy.

Karin Furlato (K)

Department of Mental Health, Azienda USL Bolzano, Italy.

Michela Pratelli (M)

Department of Mental Health, Riccione, Italy.

Mirella Ruggeri (M)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Italy.

Paolo Brambilla (P)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. Electronic address: paolo.brambilla1@unimi.it.

Jorge Jovicich (J)

CIMeC, Center for Mind/Brain Sciences, University of Trento, Rovereto, Trento, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH